← Back to Dashboard

SUNPHARMA Sun Pharmaceutical Industries Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare · Nifty 50 Weight: 1.66%
₹ 1,945.00
-0.31%
1-year price · range ₹1,579–₹1,990

Live setups screens SUNPHARMA is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

Derivatives signal Short Buildup
Short sellers are loading fresh positions (OI up +2.5%) on price weakness (-0.5%).

Analysis what the data is telling us about SUNPHARMA

In the last completed session, Sun Pharmaceutical Industries Ltd. closed -0.46% with futures open interest moving +2.5%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.55, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹1,960 sits 0.8% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Sun Pharmaceutical Industries Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Sun Pharmaceutical Industries Ltd. suggests further downside pressure is likely.

F&O Positioning EOD derivatives setup

Buildup Class
Short Buildup
bias: bearish
Futures OI
16,839,200
+406350 (+2.5%)
Option PCR (OI)
0.55
heavy call writing
Max Pain Strike
₹ 1,960
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 1,951.00
yesterday's EOD close
Index Contribution
-0.005 pp
contribution to Nifty
Traded Volume
2,413,338
live shares traded today
Upcoming Earnings
no report scheduled

Technical Snapshot from 400 sessions of price history

RSI (14)
51.9
neutral momentum
52-Week High
₹ 2,046.90
-5.0% from high
52-Week Low
₹ 1,548.00
+25.6% above low
200-DMA
₹ 1,783.34
+9.1% · above trend
50-DMA
₹ 1,888.45
+3.0% from 50-DMA
1-Year Return
+18.5%
1M +0.3%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
38.6
price / earnings
P/B
5.6
price / book
ROE
return on equity
Market Cap
₹ 466,671 Cr
total market value
Dividend Yield
0.82%
trailing yield
EPS (TTM)
₹ 50.34
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

Date Side Price Value (Cr) Counterparty
2026-06-24 BUY ₹ 1,868.00 28.85 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MUTB400045794
2026-06-24 SELL ₹ 1,868.00 28.85 THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-08-25 · spot 1,945 · EOD 2026-08-07

Option writers expect range between 1,960 and 2,000+2.8% upside, +0.8% downside.
unbalanced
Call OI (writers) Strike Put OI (writers)
23,450 +3k
IV 22% Δ 0.93 θ -0.7 ν 1
1820
219,450 +1k
2,100
IV 33% Δ 0.80 θ -1.4 ν 1
1840
123,550 +10k
23,450 +3k
IV 21% Δ 0.86 θ -0.9 ν 1
1860
554,050 +3k
IV 21% Δ -0.14 θ -0.5 ν 1
1,400
IV 23% Δ 0.78 θ -1.1 ν 1
1880
117,250 -25k
IV 20% Δ -0.19 θ -0.6 ν 1
115,850 +12k
IV 20% Δ 0.73 θ -1.1 ν 1
1900
341,950 -11k
IV 20% Δ -0.26 θ -0.7 ν 1
154,000 +42k
IV 20% Δ 0.65 θ -1.1 ν 2
1920
190,750 +32k
IV 19% Δ -0.34 θ -0.8 ν 2
315,700 +73k
IV 20% Δ 0.56 θ -1.2 ν 2
1940
311,150 -19k
IV 19% Δ -0.44 θ -0.8 ν 2
790,300 +127k
IV 20% Δ 0.47 θ -1.1 ν 2
1960 S MP
568,400 -6k
IV 19% Δ -0.54 θ -0.7 ν 2
578,200 -11k
IV 20% Δ 0.37 θ -1.1 ν 2
1980
213,150 -5k
IV 19% Δ -0.64 θ -0.6 ν 2
1,643,950 +98k
IV 20% Δ 0.29 θ -0.9 ν 1
2000 R
309,750 -5k
IV 19% Δ -0.72 θ -0.5 ν 1
709,450 +5k
IV 20% Δ 0.22 θ -0.8 ν 1
2020
165,200
IV 12% Δ -0.92 θ +0.1 ν 1
565,250 +39k
IV 20% Δ 0.16 θ -0.7 ν 1
2040
253,400 -7k
IV 20% Δ -0.84 θ -0.3 ν 1
450,450 +8k
2060
33,250 -20k
IV 20% Δ -0.89 θ -0.1 ν 1

Chain Interpretation

Spot Underlying 1,945.01
Key Resistance (R) 2,000
Key Support (S) 1,960
Max Pain Strike (MP) 1,960
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for SUNPHARMA options · 2026-08-25 expiry

Underlying: SUNPHARMA · Spot: ₹ 1,945.01 · Expiry: 2026-08-25 · Lot: 350

Legs

Side
Type
Strike
Qty
Premium
Net premium
Max profit
Max loss
Breakevens
Position Delta
Position Theta/day
Position Vega/1% IV

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

SUNPHARMA — frequently asked questions

What is the Sun Pharmaceutical Industries Ltd. share price today?

SUNPHARMA is trading at ₹1,945.00 (-0.31% vs previous close), per the latest update on this page.

What is the P/E ratio of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA (Sun Pharmaceutical Industries Ltd.) has a trailing twelve-month P/E ratio of 38.6.

What is the market cap of Sun Pharmaceutical Industries Ltd.?

SUNPHARMA has a market capitalisation of approximately ₹466,671 crore.

Is SUNPHARMA near its 52-week high?

SUNPHARMA is trading -5.0% from its 52-week high of ₹2,046.90 as of 2026-08-07.

What is the RSI of SUNPHARMA?

The 14-day RSI of SUNPHARMA is 51.9, which is considered neutral.

Is SUNPHARMA above its 200-day moving average?

SUNPHARMA is trading above its 200-DMA of ₹1,783.34 (+9.1% away).

What is the F&O buildup in SUNPHARMA?

The latest end-of-day derivatives data classifies SUNPHARMA as Short Buildup (bias: bearish), based on the day's combined price and open-interest change.

What is the max pain and PCR for SUNPHARMA options?

SUNPHARMA's option-chain max pain strike is ₹1,960 and its put-call ratio (OI) is 0.55, from the latest end-of-day option chain.

Are FIIs or big investors buying SUNPHARMA?

Strota tracks every bulk and block deal in SUNPHARMA with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.